Terpenia Phytotherapeutics produces organic full-spectrum cannabis extracts in full compliance with EU standards and regulations. Our distribution network includes wholesalers, pharmaceutical companies and research facilities worldwide. With our research focus on pain therapy and palliative medicine, we aim to raise the level of patient care through innovative therapeutic approaches.The base of our operations is our 3000m² state of the art greenhouse in northern Greece. It is where we grow our purely organic medical cannabis, paying careful attention to plant genetics and monitoring active ingredient content. At our adjacent extraction facility, we produce a full spectrum extract that contains a large number of cannabinoids, as well as most terpenes and flavonoids. We provide a high quality end-product that is flexible and safe to dose due to its constant active ingredient content. The cannabinoid THC is one of the key components of pharmaceutical cannabis extracts. However, the psychotropic effects of high doses of THC are generally seen as an undesirable side effect in the context of medical applications. The development of a compound based on natural cannabinoids with greatly reduced psychotropic side effects is at the forefront of our research and development efforts. We are committed to ecological and ethical production and business practices. We follow traditional, gmo- and pesticide-free methods of cultivation, meeting modern quality standards and safety requirements. The ecological sustainability of the environment has the utmost priority in our company. Our team consists of internationally acclaimed experts from the fields of medicine, molecular biomedicine and botany.
